These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 14502119

  • 1. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy.
    Baker DE.
    Rev Gastroenterol Disord; 2003; 3(3):150-7. PubMed ID: 14502119
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB, Barclay ML.
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
    Sanderson J, Ansari A, Marinaki T, Duley J.
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
    [Abstract] [Full Text] [Related]

  • 6. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
    Clunie GP, Lennard L.
    Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
    [Abstract] [Full Text] [Related]

  • 7. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ, Gearry RB, Begg EJ, Zhang M, Barclay ML.
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [Abstract] [Full Text] [Related]

  • 8. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
    Gisbert JP, Niño P, Rodrigo L, Cara C, Guijarro LG.
    Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
    [Abstract] [Full Text] [Related]

  • 9. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH.
    Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102
    [Abstract] [Full Text] [Related]

  • 10. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
    Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA.
    J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
    [Abstract] [Full Text] [Related]

  • 11. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
    Winter JW, Gaffney D, Shapiro D, Spooner RJ, Marinaki AM, Sanderson JD, Mills PR.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1069-77. PubMed ID: 17439508
    [Abstract] [Full Text] [Related]

  • 12. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A, Ghandi N, Hallaji Z, Chams-Davatchi C, Valikhani M, Karbakhsh Davari M.
    Arch Dermatol; 2008 Sep 01; 144(9):1143-7. PubMed ID: 18794458
    [Abstract] [Full Text] [Related]

  • 13. Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression.
    Leung M, Piatkov I, Rochester C, Boyages SC, Leong RW.
    Intern Med J; 2009 Feb 01; 39(2):121-6. PubMed ID: 19356188
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity].
    Corominas H, Díaz C, Vázquez G, Baiget M.
    Rev Esp Enferm Dig; 2002 Oct 01; 94(10):635-6. PubMed ID: 12647415
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1137-41. PubMed ID: 16611274
    [Abstract] [Full Text] [Related]

  • 17. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
    Seidman EG.
    Rev Gastroenterol Disord; 2003 Apr 15; 3 Suppl 1():S30-8. PubMed ID: 12684587
    [Abstract] [Full Text] [Related]

  • 18. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.
    Ther Drug Monit; 2007 Feb 15; 29(1):1-5. PubMed ID: 17304143
    [Abstract] [Full Text] [Related]

  • 19. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q, Zhu Q, Shang Y, Gao M, Si J.
    Digestion; 2009 Feb 15; 79(1):58-63. PubMed ID: 19252404
    [Abstract] [Full Text] [Related]

  • 20. Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase.
    Perri D, Cole DE, Friedman O, Piliotis E, Mintz S, Adhikari NK.
    Eur Respir J; 2007 Nov 15; 30(5):1014-7. PubMed ID: 17978158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.